Molecule Structure

Scientific Name

Encainide

Description of the Drug

Encainide is a voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ventricular tachycardia, that is no longer used due to proarrhythmic adverse effects.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01228

Brand Name(s)

Not Available

Company Owner(s)

Not Available

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium channel alpha subunit PROTEIN FAMILY BLOCKER CHEMBL2331043

Unichem Links

SureChEMBL SCHEMBL94346
Human Metabolome Database HMDB0015359
WDI ENCAINIDE
DrugBank DB01228
PubChem: Thomson Pharma 15373859
PubChem 48041
Nikkaji J1.621.570H
EPA CompTox Dashboard DTXSID0022983
DrugCentral 1007
ChemicalBook CB0969673
GSRS 78fb704a-4f57-4a0e-8ff8-7b22e3c8b51b
rxnorm ENCAINIDE ENCAINIDE HYDROCHLORIDE
PubChem: Drugs of the Future 12012630
KEGG Ligand C06978
ChEBI 4788